Derm In-Review welcomes our advertising supporters
At UCB, everything we do starts with a simple question: “How will this make a difference to the lives of people living with severe diseases?” We have a passionate, long-term commitment to discovering and developing innovative medicines that transform the lives of people living with severe diseases of the immune system and the central nervous system. We do that by connecting with patients and their families around the world living with the physical and social burdens of severe disease. Those connections offer new perspectives, drive innovation, and offer the hope of a new generation of therapies that are helping to transform lives.
With a team of more than 7,500 employees and operations in 40 countries, we are a global biopharmaceutical company investing nearly 25% of revenue in cutting-edge scientific research to meet unmet patient needs. The company is based in Brussels, Belgium, with U.S. headquarters located in Atlanta, Georgia.
Learn more at https://www.ucb.com/
Arcutis Biotherapeutics, a medical dermatology company that champions meaningful innovation to address the urgent needs of individuals living with immune-mediated dermatological diseases and condition
Learn more at https://www.arcutis.com/
Novartis is an innovative medicines company. Every day, we work to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach more than 250 million people worldwide.
Learn more at www.novartis.com.
Sanofi is a R&D driven, AI-powered biopharma company committed to improving people’s lives and creating compelling growth. Their team is guided by one purpose: to chase the miracles of science to improve people’s lives
Learn more at www.sanofi.com
Regeneron, a leading biotechnology company, develops medicines for serious diseases. Founded by physician-scientists, their ability to translate science into medicine has led to numerous FDA-approved treatments and investigational candidates.
Learn more at www.regeneron.com
Sun Pharma is a leading global pharmaceutical company with specialty and generic presence in the world’s largest pharma markets. The Company has solidified its position as a major player in the U.S. generics market and is continuously expanding its footprint in the specialty segment, focusing on dermatology, ophthalmology, and oncology.
Learn more at: https://sunpharma.com/
